share_log

Cyclacel Pharmaceuticals Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dellora Investments Master Fund LP(0%),Dellora Investments LP(0%), etc.

Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G/A:超過5%持股股東披露文件(修正)-Dellora Investments Master Fund LP(0%),Dellora Investments LP(0%)等

美股SEC公告 ·  02/14 10:15
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息